Skip to content

VDM PHARMACARE

Active
Private limited companyfounded 2025active for 1 yearHeiveld 76, 1745 Opwijk, BelgiumKBO/BCE: BE 1020.153.453
Summary

VDM PHARMACARE has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €26,824 and a net result of €27,057. Its solvency ranks better than 54% of 39,200 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Activities of head offices
NACE 70100
1 site
Size
≈ €110,000turnover 2025, estimated
Equity
€26,824
Profit
€27,057
Turnover estimated from the gross margin
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 2 days early
Why 95raises riskFounded in 2025lowers riskSector: Activities of head offices; management consultancy activities (NACE 70)Liquidity: current ratio 2.52, cash €9,737Figures for financial year 2025 (filed 29-07-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 63% of its sector peers (NACE 70, micro)
Financial strength
Strong
Solvency 85
equity 60.3% of total assets
Liquidity 59
short-term debt 39.7% · cash 21.9%
Profitability 100
return on assets 60.8%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (48,493 companies, NACE 70, micro)
Last 24 months 03-2026: 0.4% 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.4%● unchanged vs 06-2026highest value 08-2026: < 0.1%▼ -0.4 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity ample (current ratio 2.52, above the usual 1.5; short-term debt: 39.7% and cash: 21.9% of total assets), and 39.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro): better than 55% on solvency, 50% on liquidity and 84% on profitability.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Activities of head offices; management consultancy activities (NACE 70)
KBO
lowers risk · Liquidity: current ratio 2.52, cash €9,737
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 29-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
2 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointments: DE MARRE Veronique, D’HAESE…

Key points

  • Board3 directors in office 3 View
  • Total assets 2025first financial year filed €44,484 View
  • Active since 2025founded 19-02-2025 1 years View

By topic

Financials

Financial year
2025
Total assets
€44,484
Profit
€27,057
Solvency
60.3%
Go to Financials

Board & ownership

Board
3 members
  • DE MARRE LaurensDirector
  • DE MARRE VeroniqueDirector
  • D’HAESE Chantal Marie GermaineDirector
Go to Board & ownership

Company details

Sites
1
Legal form
Private limited company
Activity
Activities of head officesNACE 70100
Founded
19-02-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about VDM PHARMACARE

What is the company number of VDM PHARMACARE?
1020.153.453. In Belgium the VAT number is the company number with BE in front: BE 1020.153.453.
Where is VDM PHARMACARE based?
The registered office is at Heiveld 76, 1745 Opwijk.Company details
What does VDM PHARMACARE do?
According to the KBO register, the main activity is activities of head offices (NACE 70100).
What is the legal form of VDM PHARMACARE?
Private limited company (BV).
When was VDM PHARMACARE founded?
On 19-02-2025.
Is VDM PHARMACARE still active?
Yes, VDM PHARMACARE is an active enterprise in the KBO register.
What is the turnover of VDM PHARMACARE?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is VDM PHARMACARE profitable?
In financial year 2025, VDM PHARMACARE made a profit of €27,057.
Where can I find the annual accounts of VDM PHARMACARE?
VDM PHARMACARE filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to VDM PHARMACARE

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.